InvestorsObserver
×
News Home

Is Repligen Corporation (RGEN) a Stock to Watch After Losing -0.19% This Week?

Monday, September 13, 2021 01:11 PM | InvestorsObserver Analysts

Mentioned in this article

Is Repligen Corporation (RGEN) a Stock to Watch After Losing -0.19% This Week?

Repligen Corporation (RGEN) stock is down 0.19% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Repligen Corporation has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on RGEN!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With RGEN Stock Today?

Repligen Corporation (RGEN) stock is lower by -1.07% while the S&P 500 is higher by 0.11% as of 12:50 PM on Monday, Sep 13. RGEN has fallen -$3.16 from the previous closing price of $295.03 on volume of 305,054 shares. Over the past year the S&P 500 has gained 31.92% while RGEN is higher by 95.00%. RGEN earned $1.78 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 163.9.

More About Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States. Click Here to get the full Stock Report for Repligen Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App